TRPA1 Gene

TRPA1 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TRPA1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TRPA1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>8q21.11</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>8980</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q8IUM7</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>959 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~108 kDa</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Non-selective calcium-permeable cation channel</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>ANKTM1</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Sensory neurons, CNS neurons, glia, airway epithelium, GI tract</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Company</td>
</tr>
<tr>
<td class="label">GRC 6211</td>
<td>Glenmark</td>
</tr>
<tr>
<td class="label">HC-030031</td>
<td>Hydra Biosciences</td>
</tr>
<tr>
<td class="label">Compound 124</td>
<td>multiple</td>
</tr>
<tr>
<td class="label">Chembridge 5861528</td>
<td>Chembridge</td>
</tr>
<tr>
<td class="label">A-967079</td>
<td>multiple</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href=

TRPA1 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TRPA1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TRPA1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>8q21.11</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>8980</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q8IUM7</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>959 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~108 kDa</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Non-selective calcium-permeable cation channel</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>ANKTM1</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Sensory neurons, CNS neurons, glia, airway epithelium, GI tract</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Company</td>
</tr>
<tr>
<td class="label">GRC 6211</td>
<td>Glenmark</td>
</tr>
<tr>
<td class="label">HC-030031</td>
<td>Hydra Biosciences</td>
</tr>
<tr>
<td class="label">Compound 124</td>
<td>multiple</td>
</tr>
<tr>
<td class="label">Chembridge 5861528</td>
<td>Chembridge</td>
</tr>
<tr>
<td class="label">A-967079</td>
<td>multiple</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">210 edges</a></td>
</tr>
</table>

Overview

TRPA1 (Transient Receptor Potential Cation Channel Subfamily A Member 1) encodes a non-selective calcium-permeable cation channel that serves as a primary sensor for oxidative stress, electrophilic irritants, and inflammatory mediators. As the founding member of the TRPA subfamily within the larger TRP channel superfamily, TRPA1 is uniquely positioned at the intersection of sensory detection and neuroinflammatory signaling[@paul2019].

TRPA1 is expressed not only in peripheral sensory [neurons](/entities/neurons) of the dorsal root and trigeminal ganglia but also in central nervous system neurons, astrocytes, and microglia. This broad expression enables TRPA1 to contribute to neuropathic pain, neuroinflammation, and the neurodegenerative cascades seen in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease)[@nilius2019].

The channel's unusual sensitivity to electrophilic compounds and reactive oxygen species (ROS) makes it a particularly important component of the neuronal stress response. When activated, TRPA1 admits calcium and sodium, depolarizing the cell and triggering calcium-dependent signaling cascades that can be either protective or destructive depending on context, intensity, and duration of activation[@jaescu2019].

Gene and Protein Information

TRPA1 is a tetrameric channel with six transmembrane domains per subunit and intracellular N- and C-termini. The N-terminus contains multiple ankyrin repeat domains (14-18) that are involved in ligand sensing and protein-protein interactions. The channel pore is located between transmembrane helices 5 and 6, and like other TRP channels, forms a tetrameric pore structure.

Normal Function

Biophysical Properties

TRPA1 is a non-selective cation channel with significant permeability to:

• Calcium (Ca2+): P Ca / P Na ~ 5-10, making it a key calcium entry pathway
• Sodium (Na+): Contributing to depolarization
• Cesium (Cs+): Used experimentally to characterize the channel
• Magnesium (Mg2+): Lower permeability

• Outward rectification in symmetric ionic conditions
• Voltage-dependent activation — channel open probability increases with depolarization
• Rapid desensitization upon sustained agonist exposure in some contexts
• Calcium-dependent inactivation — elevated intracellular Ca2+ reduces channel activity

Activation Mechanisms

TRPA1 is activated by an unusually diverse array of chemical and physical stimuli:

Electrophilic agonists (covalent activation):

• Allyl isothiocyanate (mustard oil) — from mustard, wasabi
• Cinnamaldehyde — from cinnamon
• Acrolein — from tobacco smoke, lipid peroxidation
• Diallyl disulfide — from garlic
• Hydrochloric acid — activates at low pH

• Menthol — though TRPA1 is activated by cold (17°C) and inhibited by menthol at warm temperatures
• Delta-9-tetrahydrocannabinol (THC)
• Endogenous cannabinoids (AEA, 2-AG at high concentrations)
• 4-hydroxynonenal (4-HNE) — a lipid peroxidation product
• Formalyn — reactive aldehyde from formaldehyde
• Icilin — synthetic super agonist

• Cooling below ~17°C
• Mechanical stretch of the membrane
• Voltage — depolarization increases open probability

• Reactive oxygen species (ROS): H2O2, NO, peroxynitrite
• Lipid peroxidation products: 4-HNE, 4-ONE, acrolein
• Pro-inflammatory mediators: Bradykinin, prostaglandins (indirect via PKC)
• Amyloid-beta (1-42): Direct activation of TRPA1 on neurons[@lee2019]
• Alpha-synuclein oligomers: Activation in dopaminergic neurons[@chen2018]

Signal Transduction

Role in Neurodegeneration

Alzheimer's Disease

Amyloid-beta activation of TRPA1: Aβ1-42 directly activates TRPA1 channels on hippocampal and cortical neurons, leading to calcium influx, mitochondrial dysfunction, and neuronal death. This establishes TRPA1 as both a sensor and effector of amyloid toxicity[@lee2019].

Oxidative stress amplification: AD brains show elevated ROS and lipid peroxidation products (4-HNE, acrolein) that activate TRPA1. This creates a feedforward cycle: Aβ triggers ROS → ROS activates TRPA1 → TRPA1 admits Ca2+ → mitochondrial dysfunction → more ROS[@andersson2020].

Neuroinflammation: TRPA1 activation on astrocytes and microglia promotes release of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6), driving the chronic neuroinflammation that characterizes AD.

Therapeutic potential: TRPA1 antagonists could interrupt the Aβ-TRPA1-ROS cycle, potentially protecting neurons and reducing neuroinflammation. Several TRPA1 antagonists have shown efficacy in AD mouse models[@koivisto2022].

Parkinson's Disease

Alpha-synuclein-TRPA1 interaction: Alpha-synuclein oligomers activate TRPA1 on dopaminergic neurons, contributing to their vulnerability. TRPA1 activation by α-synuclein induces calcium dysregulation and oxidative stress, accelerating the degenerative process[@chen2018].

Dopaminergic neuron vulnerability: The high metabolic rate and calcium-dependent pacemaking activity of dopaminergic neurons in the [substantia nigra pars compacta](/brain-regions/substantia-nigra) make them particularly sensitive to TRPA1-mediated calcium overload.

L-DOPA-induced dyskinesia: TRPA1 may contribute to the development of L-DOPA-induced dyskinesias (LID) through its role in sensitizing striatal neurons. TRPA1 antagonists have shown anti-dyskinetic effects in PD models.

Mitochondrial dysfunction: Like in AD, TRPA1-mediated calcium influx disrupts mitochondrial function in PD neurons, generating additional ROS and amplifying the pathogenic cascade.

Neuropathic Pain

TRPA1 is a primary mediator of neuropathic pain from multiple causes:

Chemotherapy-induced peripheral neuropathy (CIPN): Chemotherapy agents (oxaliplatin, paclitaxel, vincristine) generate ROS and electrophilic metabolites that activate TRPA1 on sensory neurons, causing cold allodynia and mechanical hyperalgesia[@rose2014].

Diabetic neuropathy: Hyperglycemia increases ROS production and advanced glycation end-products (AGEs) that activate TRPA1, contributing to the burning pain and sensory loss in diabetic patients[@chen2020].

Trigeminal neuralgia and migraine: TRPA1 activation on trigeminal ganglion neurons contributes to craniofacial pain syndromes, including migraine with aura where oxidative stress is elevated[@huang2019].

HIV-related neuropathy: HIV coat protein gp120 and antiretroviral drugs (e.g., stavudine) can activate TRPA1, contributing to HIV-associated sensory neuropathy.

Neuroinflammation

TRPA1 on non-neuronal cells significantly contributes to neuroinflammation:

Microglial activation: TRPA1 activation on microglia promotes their transition to a pro-inflammatory (M1) phenotype, releasing IL-1β, TNF-α, and IL-6. This contributes to the chronic neuroinflammation seen in all major neurodegenerative diseases[@nilius2019].

Astrocyte calcium signaling: TRPA1-mediated calcium transients in astrocytes dysregulate their homeostatic functions, including potassium buffering, glutamate uptake, and water transport.

Blood-brain barrier dysfunction: TRPA1 activation on endothelial cells may contribute to BBB disruption, allowing peripheral immune cells and molecules to enter the CNS.

Molecular Mechanisms

Calcium-Dependent Signaling Cascade

TRPA1-mediated calcium influx triggers multiple downstream pathways:

Mitochondrial Calcium Overload

Sustained TRPA1 activation leads to mitochondrial Ca2+ overload:

• Impaired oxidative phosphorylation → reduced ATP
• Opening of mitochondrial permeability transition pore (mPTP)
• Release of cytochrome c → activation of apoptosis
• Generation of additional ROS from damaged mitochondria

Interaction with Other TRP Channels

TRPA1 functionally interacts with other TRP channels:

• TRPV1: Co-expression in nociceptive neurons; shared signaling pathways
• TRPM8: TRPA1 can be inhibited by TRPM8 agonists (menthol) at certain temperatures
• TRPC channels: Store-operated calcium entry can be modulated by TRPA1 activity

Desensitization and Trafficking

• Calcium-dependent desensitization: High intracellular Ca2+ reduces TRPA1 activity through CaM
• Phosphorylation by PKA/PKC: Alters channel sensitivity and trafficking
• Ubiquitin-mediated degradation: Prolonged activation leads to channel removal from the membrane
• Trafficking to membrane: Activation can also mobilize intracellular pools to the plasma membrane

Therapeutic Development

TRPA1 Antagonists

Multiple pharmaceutical companies have developed TRPA1 antagonists:

Clinical Applications

Pain disorders: TRPA1 antagonists are developed for chronic pain conditions including:

• Neuropathic pain from diabetes, chemotherapy, HIV
• Migraine and trigeminal neuralgia
• Osteoarthritis pain
• Visceral pain

Neurodegeneration: Emerging applications in AD and PD, targeting:

• Neuronal calcium dysregulation
• [Neuroinflammation](/mechanisms/neuroinflammation) Oxidative stress amplification[@koivisto2022]

Challenges in Drug Development

• Species differences: Human and rodent TRPA1 have different pharmacological profiles
• Limited CNS penetration: Many early antagonists did not cross the blood-brain barrier
• On-target toxicity: TRPA1 in the GI tract and other tissues may cause side effects
• Compensatory mechanisms: Redundant pain pathways may limit efficacy as monotherapy

Gene Interactions and Network

• TRPV1 (capsaicin receptor) — Co-expressed in nociceptors; shared sensitizing mechanisms
• TRPM8 (cold receptor) — Functional interactions in thermoreception
• CALM1/2 (Calmodulin) — Mediates calcium-dependent desensitization
• PRKCE (PKC epsilon) — Phosphorylates and sensitizes TRPA1
• CAMK2A — Calcium-dependent kinase downstream of TRPA1
• MAPK1/3 (ERK1/2) — Activated by TRPA1-mediated calcium
• NFKB1 — Pro-inflammatory gene transcription downstream
• PTGS2 (COX-2) — Induced by TRPA1 activation in inflammation
• SNCA (alpha-synuclein) — Activates TRPA1 in PD models
• APP (amyloid precursor protein) — A-beta activates TRPA1

Research Challenges and Open Questions

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neuropathic Pain](/mechanisms/neuropathic-pain)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [TRPV1 Gene](/genes/trpv1)
• [Calcium Signaling](/mechanisms/calcium-signaling-neurodegeneration)
• [Transient Receptor Potential Channels](/mechanisms/trp-channel-signaling)

Pathway Diagram

The following diagram shows the key molecular relationships involving TRPA1 Gene discovered through SciDEX knowledge graph analysis: